68 results
425
EX-2.5
ONCT
Oncternal Therapeutics Inc
7 Mar 19
Business combination disclosure
7:31am
the “Lock-Up Period” with respect thereto.
The undersigned agrees that the Lock-Up Restrictions preclude the undersigned from engaging in any hedging … in a sale or disposition of such Securities even if such Securities would be disposed of by someone other than the undersigned. Such prohibited hedging
8-K
EX-2.5
ONCT
Oncternal Therapeutics Inc
7 Mar 19
Entry into a Material Definitive Agreement
7:33am
the “Lock-Up Period” with respect thereto.
The undersigned agrees that the Lock-Up Restrictions preclude the undersigned from engaging in any hedging … in a sale or disposition of such Securities even if such Securities would be disposed of by someone other than the undersigned. Such prohibited hedging
424B3
ONCT
Oncternal Therapeutics Inc
29 Aug 14
Prospectus supplement
12:00am
at a stipulated price per share;
· through the writing or settlement of options or other hedging transactions, whether through an options exchange … of the shares of common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial
424B3
ONCT
Oncternal Therapeutics Inc
9 Jan 15
Prospectus supplement
12:00am
price per share;
· through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise … of common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions
8-K
EX-10.1
ukkiaqdcyjc rtyalc
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
8-K
EX-10.1
8yiiv 9pywdv
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
8-K
EX-2.4
puvhb5s9 4ju5d6yw3a
7 Mar 19
Entry into a Material Definitive Agreement
7:33am
425
EX-2.4
rsn md4bdckvczz27qms
7 Mar 19
Business combination disclosure
7:31am
425
EX-2.3
tj1b8ouelxb
7 Mar 19
Business combination disclosure
7:31am
8-K
EX-2.3
anlouaqzgxs7q7kjnoo
7 Mar 19
Entry into a Material Definitive Agreement
7:33am
8-K
EX-4.2
8nzctxe71wmcb
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
8-K
EX-4.2
y5id0 gav9
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
8-K
EX-4.1
ljadf
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
424B3
n4e qdcuuajn34mu
15 Apr 21
Prospectus supplement
4:31pm
8-K
EX-1.1
rw192r1w0 qxq4
12 Oct 05
GTx Prices Public Offering of Common Stock
12:00am